This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
1yc1
From Proteopedia
(Difference between revisions)
| Line 20: | Line 20: | ||
==About this Structure== | ==About this Structure== | ||
| - | 1YC1 is a | + | 1YC1 is a 1 chain structure of sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1YC1 OCA]. |
==Reference== | ==Reference== | ||
| - | + | <ref group="xtra">PMID:15713410</ref><references group="xtra"/> | |
[[Category: Homo sapiens]] | [[Category: Homo sapiens]] | ||
| - | [[Category: Single protein]] | ||
[[Category: Brinker, A.]] | [[Category: Brinker, A.]] | ||
[[Category: Caldwell, J.]] | [[Category: Caldwell, J.]] | ||
| Line 39: | Line 38: | ||
[[Category: Drug design]] | [[Category: Drug design]] | ||
| - | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on | + | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Wed Feb 18 08:27:53 2009'' |
Revision as of 06:27, 18 February 2009
Crystal Structures of human HSP90alpha complexed with dihydroxyphenylpyrazoles
Template:ABSTRACT PUBMED 15713410
About this Structure
1YC1 is a 1 chain structure of sequence from Homo sapiens. Full crystallographic information is available from OCA.
Reference
- Kreusch A, Han S, Brinker A, Zhou V, Choi HS, He Y, Lesley SA, Caldwell J, Gu XJ. Crystal structures of human HSP90alpha-complexed with dihydroxyphenylpyrazoles. Bioorg Med Chem Lett. 2005 Mar 1;15(5):1475-8. PMID:15713410 doi:10.1016/j.bmcl.2004.12.087
Page seeded by OCA on Wed Feb 18 08:27:53 2009
Categories: Homo sapiens | Brinker, A. | Caldwell, J. | Choi, H. | Gu, X. | Han, S. | He, Y. | Kreusch, A. | Lesley, S A. | Zhou, V. | Cancer | Cell-cycle | Drug design
